These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18367236)

  • 21. Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria.
    Eckstein J; Verheule S; de Groot NM; Allessie M; Schotten U
    Prog Biophys Mol Biol; 2008; 97(2-3):435-51. PubMed ID: 18378284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadolinium decreases stretch-induced vulnerability to atrial fibrillation.
    Bode F; Katchman A; Woosley RL; Franz MR
    Circulation; 2000 May; 101(18):2200-5. PubMed ID: 10801762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechano-electric feedback in right atrium after left ventricular infarction in rats.
    Kamkin A; Kiseleva I; Wagner KD; Leiterer KP; Theres H; Scholz H; Günther J; Lab MJ
    J Mol Cell Cardiol; 2000 Mar; 32(3):465-77. PubMed ID: 10731445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel anti-arrhythmic agents for the treatment of atrial fibrillation.
    Wettwer E; Christ T; Dobrev D; Ravens U
    Curr Opin Pharmacol; 2007 Apr; 7(2):214-8. PubMed ID: 17303472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the renin-angiotensin system: effects on tachycardia-induced early electrical remodelling in rabbit atrium.
    Laszlo R; Eick C; Rueb N; Weretka S; Weig HJ; Schreieck J; Bosch RF
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):125-32. PubMed ID: 18957382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential].
    Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
    Dtsch Med Wochenschr; 2012 Aug; 137(33):1654-8. PubMed ID: 22875694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New pharmacological targets and treatments for atrial fibrillation.
    Carlsson L; Duker G; Jacobson I
    Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multiple ion channel blocker, NIP-142, for the treatment of atrial fibrillation.
    Tanaka H; Hashimoto N
    Cardiovasc Drug Rev; 2007; 25(4):342-56. PubMed ID: 18078434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation.
    Oliveira MM; da Silva N; Timóteo AT; Feliciano J; de Sousa L; Santos S; Marques F; Ferreira R
    Rev Port Cardiol; 2007; 26(7-8):691-702. PubMed ID: 17939579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanoelectrical coupling enhances initiation and affects perpetuation of atrial fibrillation during acute atrial dilation.
    Kuijpers NH; Potse M; van Dam PM; ten Eikelder HM; Verheule S; Prinzen FW; Schotten U
    Heart Rhythm; 2011 Mar; 8(3):429-36. PubMed ID: 21075218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small conductance calcium activated K
    Yan Y; Skarsfeldt MA; Diness JG; Bentzen BH
    Int J Cardiol Heart Vasc; 2021 Dec; 37():100898. PubMed ID: 34746364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of gadolinium on stretch-induced changes in contraction and intracellularly recorded action- and afterpotentials of rat isolated atrium.
    Tavi P; Laine M; Weckström M
    Br J Pharmacol; 1996 May; 118(2):407-13. PubMed ID: 8735645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of atrial fibrillation and action of drugs used in its management.
    Grant AO
    Am J Cardiol; 1998 Oct; 82(8A):43N-49N. PubMed ID: 9809900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial fibrillation: a progressive atrial myopathy or a distinct disease?
    Kallergis EM; Goudis CA; Vardas PE
    Int J Cardiol; 2014 Feb; 171(2):126-33. PubMed ID: 24388634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refractoriness in human atria: Time and voltage dependence of sodium channel availability.
    Skibsbye L; Jespersen T; Christ T; Maleckar MM; van den Brink J; Tavi P; Koivumäki JT
    J Mol Cell Cardiol; 2016 Dec; 101():26-34. PubMed ID: 27773652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tarantula peptide inhibits atrial fibrillation.
    Bode F; Sachs F; Franz MR
    Nature; 2001 Jan; 409(6816):35-6. PubMed ID: 11343101
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechano-electrical feedback underlying arrhythmias: the atrial fibrillation case.
    Franz MR; Bode F
    Prog Biophys Mol Biol; 2003; 82(1-3):163-74. PubMed ID: 12732276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of atrial structural and functional changes in the development and progression of atrial fibrillation].
    Aparina OP; Chikhireva LN; Mironova NA; Mironova ES; Bakalov SA
    Ter Arkh; 2014; 86(1):71-7. PubMed ID: 24754073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute electrophysiologic effects of the polyphenols resveratrol and piceatannol in rabbit atria.
    Frommeyer G; Wolfes J; Ellermann C; Kochhäuser S; Dechering DG; Eckardt L
    Clin Exp Pharmacol Physiol; 2019 Jan; 46(1):94-98. PubMed ID: 29956844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring Refractoriness as an Adjunctive Electrical Biomarker for Staging of Atrial Fibrillation.
    van Staveren LN; de Groot NMS
    J Am Heart Assoc; 2020 Dec; 9(23):e018427. PubMed ID: 33238778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.